Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Comparative Immunology, Microbiology and Infectious Diseases
|
October 17, 2020
Hepatic and splenic immune response during acute vs. chronic Brucella melitensis infection using in situ microscopy
Juliane Daggett, Alexandra Rogers, Jerome Harms, et al.
Journal of the American Veterinary Medical Association
|
August 29, 2020
Pathology in Practice
Juliane Daggett, Shawna Hawkins, Kristen Phair, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2020
Kidney Subcapsular Allograft Transplants as a Model to Test Virus-Derived Chemokine-Modulating Proteins as Therapeutics
Michelle Burgin, Jordan R Yaron, Liqiang Zhang, et al.
Cancers
|
January 21, 2022
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
John D Christie, Nicole Appel, Liqiang Zhang, et al.
ACS Biomaterials Science & Engineering
|
July 10, 2025
Modulation of Secondary Structure, Bioavailability, Immunomodulation, and Tissue Repair Outcomes Using Differential Processing of Silk Biomaterials
Shubham Pallod, Weston DeCambra, Trishita Chowdhury, et al.
Pharmaceutics
|
October 27, 2020
Recombinant <i>Myxoma Virus</i>-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling
Jordan R Yaron, Liqiang Zhang, Qiuyun Guo, et al.
Cancer Research Communications
|
June 28, 2023
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, et al.
Oncotarget
|
March 7, 2022
Transplantation of autologous bone marrow pre-loaded <i>ex vivo</i> with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma
Nancy Y Villa, Masmudur M Rahman, Joseph Mamola, et al.
Molecular Therapy Oncolytics
|
July 23, 2020
Autologous Transplantation Using Donor Leukocytes Loaded <i>Ex Vivo</i> with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma
Nancy Y Villa, Masmudur M Rahman, Joseph Mamola, et al.
Pathogens (Basel, Switzerland)
|
May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage
Isabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Comparative Immunology, Microbiology and Infectious Diseases
|
October 17, 2020
Hepatic and splenic immune response during acute vs. chronic Brucella melitensis infection using in situ microscopy
Juliane Daggett, Alexandra Rogers, Jerome Harms, et al.
Journal of the American Veterinary Medical Association
|
August 29, 2020
Pathology in Practice
Juliane Daggett, Shawna Hawkins, Kristen Phair, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 27, 2020
Kidney Subcapsular Allograft Transplants as a Model to Test Virus-Derived Chemokine-Modulating Proteins as Therapeutics
Michelle Burgin, Jordan R Yaron, Liqiang Zhang, et al.
Cancers
|
January 21, 2022
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma
John D Christie, Nicole Appel, Liqiang Zhang, et al.
ACS Biomaterials Science & Engineering
|
July 10, 2025
Modulation of Secondary Structure, Bioavailability, Immunomodulation, and Tissue Repair Outcomes Using Differential Processing of Silk Biomaterials
Shubham Pallod, Weston DeCambra, Trishita Chowdhury, et al.
Pharmaceutics
|
October 27, 2020
Recombinant <i>Myxoma Virus</i>-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling
Jordan R Yaron, Liqiang Zhang, Qiuyun Guo, et al.
Cancer Research Communications
|
June 28, 2023
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
Masmudur M Rahman, Fleur van Oosterom, Junior A Enow, et al.
Oncotarget
|
March 7, 2022
Transplantation of autologous bone marrow pre-loaded <i>ex vivo</i> with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma
Nancy Y Villa, Masmudur M Rahman, Joseph Mamola, et al.
Molecular Therapy Oncolytics
|
July 23, 2020
Autologous Transplantation Using Donor Leukocytes Loaded <i>Ex Vivo</i> with Oncolytic Myxoma Virus Can Eliminate Residual Multiple Myeloma
Nancy Y Villa, Masmudur M Rahman, Joseph Mamola, et al.
Pathogens (Basel, Switzerland)
|
May 28, 2022
Virus-Derived Chemokine Modulating Protein Pre-Treatment Blocks Chemokine-Glycosaminoglycan Interactions and Significantly Reduces Transplant Immune Damage
Isabela R Zanetti, Michelle Burgin, Liqiang Zhang, et al.
Page
of 1